Susan Manzi, MD, MPH

Allegheny Health Network
Pittsburgh, Pennsylvania, United States

To be added.

Presentation(s):

• 1545: Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: Interim Analysis of a Phase 3 Randomized Placebo-controlled Study

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): CAQH: Advisor or Review Panel Member (Ongoing); Cartesian Therapeutics: Consultant (Ongoing); Miltenyi: DSMB (Ongoing)